Chinese companies have over the past five years obtained exclusive distribution rights in Taiwan for 29 percent of new pharmaceuticals, the Legislative Yuan said, urging the government to intervene, as it said the issue extends far beyond Chinese agency over the Pfizer-BioNTech COVID-19 vaccine.
Right of agency for drug distribution has received widespread attention this year, after Germany’s BioNTech inked a deal with Shanghai Fosun Pharmaceutical Group (上海復星醫藥集團) to develop and distribute its COVID-19 vaccine in Taiwan, China, Hong Kong and Macau.
This has complicated Taipei’s efforts to procure the vaccine.
Private entities have stepped in to purchase doses to donate to the government, including Taiwan Semiconductor Manufacturing Co (台積電), the Buddhist Compassion Relief Tzu Chi Foundation and the Hon Hai Precision Industry Co (鴻海精密)-affiliated Yonglin Foundation.
In a report dated Monday, the Legislative Yuan’s Judiciary and Organic Laws and Statutes Bureau decried the arrangement as unreasonable.
“Requiring South Korea to purchase vaccines through a North Korean distributor or Israel to go through a Palestinian firm would be preposterous,” the report said.
Granting exclusive distribution rights in a nation to its political and military adversary is ethically problematic, it said.
Due to the antagonism and mutual distrust between the two nations, it is highly unlikely that they would complete a contract and instead use it as a tool for political manipulation, it added.
This would further hinder transactions and jeopardize the right to healthcare of the “represented country,” the report added.
Right of agency over pharmaceuticals has long been an issue, the bureau said.
Over the past five years, Chinese firms have obtained exclusive distribution rights to Taiwan for 29 percent of new pharmaceuticals, posing an increasingly serious problem that cannot be ignored, it said.
The bureau recommended that the Ministry of Foreign Affairs and national security agencies intervene in China’s attempts to monopolize Taiwan’s pharmaceutical market.
Using appropriate channels, officials should persuade multinationals to avoid signing right-of-agency contracts for Taiwan with Chinese distributors, thereby preventing human rights, moral and political controversies, it said.
All import licensing procedures should follow WTO protocols, as Taiwan, Germany and China are all members of the global trade body, the report added, recommending that the Ministry of Economic Affairs seek a decision from the WTO or another international economic forum to ensure fair and timely access to vaccines worldwide.
MORE VISITORS: The Tourism Administration said that it is seeing positive prospects in its efforts to expand the tourism market in North America and Europe Taiwan has been ranked as the cheapest place in the world to travel to this year, based on a list recommended by NerdWallet. The San Francisco-based personal finance company said that Taiwan topped the list of 16 nations it chose for budget travelers because US tourists do not need visas and travelers can easily have a good meal for less than US$10. A bus ride in Taipei costs just under US$0.50, while subway rides start at US$0.60, the firm said, adding that public transportation in Taiwan is easy to navigate. The firm also called Taiwan a “food lover’s paradise,” citing inexpensive breakfast stalls
TRADE: A mandatory declaration of origin for manufactured goods bound for the US is to take effect on May 7 to block China from exploiting Taiwan’s trade channels All products manufactured in Taiwan and exported to the US must include a signed declaration of origin starting on May 7, the Bureau of Foreign Trade announced yesterday. US President Donald Trump on April 2 imposed a 32 percent tariff on imports from Taiwan, but one week later announced a 90-day pause on its implementation. However, a universal 10 percent tariff was immediately applied to most imports from around the world. On April 12, the Trump administration further exempted computers, smartphones and semiconductors from the new tariffs. In response, President William Lai’s (賴清德) administration has introduced a series of countermeasures to support affected
CROSS-STRAIT: The vast majority of Taiwanese support maintaining the ‘status quo,’ while concern is rising about Beijing’s influence operations More than eight out of 10 Taiwanese reject Beijing’s “one country, two systems” framework for cross-strait relations, according to a survey released by the Mainland Affairs Council (MAC) on Thursday. The MAC’s latest quarterly survey found that 84.4 percent of respondents opposed Beijing’s “one country, two systems” formula for handling cross-strait relations — a figure consistent with past polling. Over the past three years, opposition to the framework has remained high, ranging from a low of 83.6 percent in April 2023 to a peak of 89.6 percent in April last year. In the most recent poll, 82.5 percent also rejected China’s
PLUGGING HOLES: The amendments would bring the legislation in line with systems found in other countries such as Japan and the US, Legislator Chen Kuan-ting said Democratic Progressive Party (DPP) Legislator Chen Kuan-ting (陳冠廷) has proposed amending national security legislation amid a spate of espionage cases. Potential gaps in security vetting procedures for personnel with access to sensitive information prompted him to propose the amendments, which would introduce changes to Article 14 of the Classified National Security Information Protection Act (國家機密保護法), Chen said yesterday. The proposal, which aims to enhance interagency vetting procedures and reduce the risk of classified information leaks, would establish a comprehensive security clearance system in Taiwan, he said. The amendment would require character and loyalty checks for civil servants and intelligence personnel prior to